Blackmore’s Conceive Well Men vs placebo in men with low sperm count and motility
Phase 4
Withdrawn
- Conditions
- Oligozoospermia (low sperm concentration)Asthenozoospermia (low sperm motility)Reproductive Health and Childbirth - Fertility including in vitro fertilisation
- Registration Number
- ACTRN12618001068257
- Lead Sponsor
- Michael Chapman
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
1. Gender: Men
2. Men with female partners who are interested in conceiving
3. A semen analysis in the previous 3 months that result in a sperm count of less than 15 million/ml or sperm motility of less than 30%
Exclusion Criteria
1. On antioxidant supplements, iron, folic acid or omega three supplements or any nutritional male fertility supplements that affect semen quality in the previous 3 months
2. Had surgical male fertility treatment in medical history
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sperm concentration (million/mL)[Baseline, 3 months post-baseline and 6 months post-baseline (primary timepoint)];Sperm total motility (%)[Baseline, 3 months post-baseline and 6 months post-baseline (primary timepoint)]
- Secondary Outcome Measures
Name Time Method Pregnancy of participants partners (positive/negative) by urine test. This test and its results are performed and derived by the subject's partners.[3 months post-baseline and 6 months post-baseline];Sperm morphology (%)[3 months post-baseline and 6 months post-baseline]